To further characterize the expression of markers involved in T cells’ exhausted and senescent status in AML patients treated with HMA plus VEN, we analyzed the expression of CD244 and CD57 on CD4+ and CD8+ T cells. This evidence concerns the gene B3GAT1 and acute myeloid leukemia.